APA (7th ed.) Citation

MT, T., D, V., B, N., G, M., N, E., C, S., & S, R. (2022). Adherence and discontinuation rates in patients on Tecfidera™ (dimethyl fumarate): Long-term Canadian experience from the Biogen ONE™ support program. Multiple sclerosis and related disorders, 67, 104080. https://doi.org/10.1016/j.msard.2022.104080

Chicago Style (17th ed.) Citation

MT, Thompson, Virginia D, Nick B, Melissa G, Engineer N, Shen C, and Reedie S. "Adherence and Discontinuation Rates in Patients on Tecfidera™ (dimethyl Fumarate): Long-term Canadian Experience from the Biogen ONE™ Support Program." Multiple Sclerosis and Related Disorders 67 (2022): 104080. https://doi.org/10.1016/j.msard.2022.104080.

MLA (9th ed.) Citation

MT, Thompson, et al. "Adherence and Discontinuation Rates in Patients on Tecfidera™ (dimethyl Fumarate): Long-term Canadian Experience from the Biogen ONE™ Support Program." Multiple Sclerosis and Related Disorders, vol. 67, 2022, p. 104080, https://doi.org/10.1016/j.msard.2022.104080.